Pharmaceutical Assistance Coordination evaluates proposals in a public session. The announcement of the winning company is expected in 2023, subject to appeals and disqualifications.

Ministry of Health extends deadline to avoid treatment interruptions in 2026; industry demands permanent law already validated by the EU

The Court's decision is expected to be delivered starting from September 2020

According to Filipe Campos, from Close-Up International, the market could expand even further with rule updates and greater medical adherence

Civil engineer creates pioneering company to boost the use of hempcrete in Brazil, even without regulation

Bio Leaf Health's investment focuses on increasing the quality of medical cannabis production at the Portalegre facility to reach market values

The UK faces a shortage of doctors and specialists in medicinal cannabis, as demand for treatments grows and the market approaches €300 million.

THC and CBD-infused beverages are gaining space worldwide. In Brazil, brands use only terpenes. Get to know some!

Participation in the Medical Cannabis Fair 2024 marks a new chapter in the company's history

The event organized by Revivid Brasil is free to attend and will feature lectures from prominent figures in the Brazilian cannabis scene

Less State and more hemp. Sustainable architecture is the key to unlocking supply and reducing housing costs in Portugal

Hemp is making its way into makeup with promises of natural beauty, but still faces challenges in regulation and skin science

The historic initiative involves over 5,400 farmers, transforms the economy of the Rif region, and solidifies the country as a leader in the global regulated market

Experts point out that the US experience can accelerate national development

Germany, Malta, and Luxembourg lead in adult use, while other European countries expand access to medical marijuana

The United Nations Commission on Narcotic Drugs (CND) approved, by a qualified majority, the recommendation to include hexahydrocannabinol (HHC) in Schedule II of the 1971 Convention on Psychotropic Substances

Between January and November 2024, hospital consumption reached 950 units, while pharmacies recorded an increase with 1,549 packages of cannabis-based products.

Company releases report on the current legislation in the European continent regarding the regulation of cannabis uses

North American country leads the market with imports valued at $55 million

A study reported that cannabis can reduce migraine and other headache pain levels by up to 50%.